Occurrence of Gastrointestinal Cancer in Users of Bisphosphonates and Other Antiresorptive Drugs Against Osteoporosis

Calcified Tissue International

Volumn 89, Issue 6, 2011, Pages 434-441

  Vestergaard, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Alendronate; Bile duct; Bisphosphonate; Cancer; Colon; Esophagus; Etidronate; Gallbladder; Liver; Pancreas; Raloxifene; Small intestine; Stomach

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; CORTICOSTEROID; ETIDRONIC ACID; IBANDRONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

AGED; ARTICLE; BILE DUCT CANCER; CANCER RISK; CAUSE OF DEATH; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DENMARK; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE CANCER; STOMACH CANCER;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; DIPHOSPHONATES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; OSTEOPOROSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 82455162461     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9539-4     Document Type: Article

References (22)

1. DK Wysowski 2009 Reports of esophageal cancer with oral bisphosphonate use N Engl J Med 360 89 90 19118315 10.1056/NEJMc0808738 1:CAS:528: DC%2BD1MXitVShug%3D%3D
2. T Terashima K Hiramatsu A Shimatani M Matsuda H Ogino Y Satomura Y Noda 2006 An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis Endoscopy 38 2 E37 17366400 10.1055/s-2006-944671
3. A Ribeiro KR DeVault JT Wolfe ME Stark 1998 Alendronate-associated esophagitis: endoscopic and pathologic features Gastrointest Endosc. 47 525 528 9647380 10.1016/S0016-5107(98)70256-1 1:STN:280:DyaK1czgvFGqtw%3D%3D (Pubitemid 28287574)
4. P de Groen D Lubbe L Hirsch A Daifotis W Stephenson D Freedholm S Pryor-Tillotson M Seleznick H Pinkas K Wang 1996 Esophagitis associated with the use of alendronate N Engl J Med 335 1016 1021 8793925 10.1056/ NEJM199610033351403 (Pubitemid 26338731)
5. WH Chow WD Finkle JK McLaughlin H Frankl HK Ziel JFJ Fraumeni 1995 The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 474 477 7629956 10.1001/jama.274.6.474 1:STN:280:DyaK2Mzls1eiug%3D%3D
6. J Lagergren R Bergström A Lindgren O Nyrén 1999 Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 825 831 10080844 10.1056/NEJM199903183401101 1:STN:280: DyaK1M7msFeitw%3D%3D (Pubitemid 29142625)
7. A Lassen J Hallas OBS de Muckadell 2006 Esophagitis: incidence and risk of esophageal adenocarcinoma-a population-based cohort study Am J Gastroenterol 101 1193 1199 16771936 10.1111/j.1572-0241.2006.00550.x (Pubitemid 43829981)
8. CR Cardwell CC Abnet MM Cantwell LJ Murray 2010 Exposure to oral bisphosphonates and risk of esophageal cancer JAMA 304 657 663 20699457 10.1001/jama.2010.1098 1:CAS:528:DC%2BC3cXhtVelsbbO
9. DM Nguyen J Schwartz P Richardson HB El-Serag 2010 Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus Dig Dis Sci 55 3404 3407 20397052 10.1007/s10620-010-1198-1 1:CAS:528:DC%2BC3cXhtl2itLjE
10. DH Solomon A Patrick MA Brookhart 2009 More on reports of esophageal cancer with oral bisphosphonate use N Engl J Med 360 1789 1792 19391255 10.1056/NEJMc096026 1:CAS:528:DC%2BD1MXkvVymu7w%3D
11. B Abrahamsen P Eiken R Eastell 2009 Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study J Bone Miner Res 24 1095 1102 19113931 10.1359/jbmr.081247 1:CAS:528:DC%2BD1MXmvFyjtrY%3D
12. J Green G Czanner G Reeves J Watson L Wise V Beral 2010 Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort BMJ 341 c4444 20813820 10.1136/bmj.c4444
13. L Sewing F Steinberg H Schmidt R Göke 2008 The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis Apoptosis 13 782 789 18437576 10.1007/s10495-008-0211-z 1:CAS:528:DC%2BD1cXlvFaisrc%3D
14. L Montella R Addeo G Palmieri M Caraglia G Cennamo B Vincenzi R Guarrasi R Mamone V Faiola N Frega E Capasso L Maiorino D Leopardo C Pizza V Montesarchio S Del Prete 2010 Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series Cancer Chemother Pharmacol 65 1137 1143 19760218 10.1007/s00280-009-1122-6 1:CAS:528:DC%2BC3cXjtlals7c%3D
15. N Penel S Dewas P Doutrelant S Clisant Y Yazdanpanah A Adenis 2008 Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis Support Care Cancer 16 387 392 17710443 10.1007/s00520-007-0322-z (Pubitemid 351667049)
16. T Andersen M Madsen J Jørgensen L Mellemkjær J Olsen 1999 The Danish National Hospital Register Dan Med Bull 46 263 268 10421985 1:STN:280:DyaK1MzltVyrtw%3D%3D
17. J Mosbech J Jørgensen M Madsen K Rostgaard K Thornberg T Poulsen 1995 The Danish National Patient Register: evaluation of data quality [in Danish] Ugeskr Laeger 157 3741 3745 7631448 1:STN:280:DyaK2Mzlsl2msA%3D%3D
18. LE Lévesque JA Hanley A Kezouh S Suissa 2010 Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 340 b5087 20228141 10.1136/bmj.b5087
19. V Bagnardi M Blangiardo C La Vecchia G Corrao 2001 Alcohol consumption and the risk of cancer: a meta-analysis Alcohol Res Health 25 263 270 11910703 1:STN:280:DC%2BD387nvVKrtA%3D%3D (Pubitemid 33708990)
20. EH Ruder AO Laiyemo BI Graubard AR Hollenbeck A Schatzkin AJ Cross 2011 Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort Am J Gastroenterol 106 1340 1350 21407185 10.1038/ajg.2011.38 1:CAS:528:DC%2BC3MXos1Kjurk%3D
21. C Carroll K Cooper D Papaioannou D Hind H Pilgrim P Tappenden 2010 Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis Clin Ther 32 789 803 20685491 10.1016/j.clinthera.2010. 04.024
22. JR Curtis JC Larson E Delzell MA Brookhart SM Cadarette R Chlebowski S Judd M Safford DH Solomon AZ Lacroix 2011 Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials Med Care 49 427 435 21422960 10.1097/MLR.0b013e318207ed9e